| Medical Advisor(Oncology) | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Medical Sales Representative โ CVRM โ (North-West Hungary) | AstraZeneca | Budapest, Hungary | 2026-06-25 |
| Medical Affairs Manager | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Medical Director, Hematology | AstraZeneca | Boston, United States | 2026-06-25 |
| Medical Science Liaison (for pooling) | AstraZeneca | Manila, Philippines | 2026-06-25 |
| Medical Advisor (for pooling) | AstraZeneca | Manila, Philippines | 2026-06-25 |
| Medical Representative (For Pooling) | AstraZeneca | Manila, Philippines | 2026-06-25 |
| Medical NPP(New Product Planning) Lead, Biopharmaceutical | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Medical Excellence Lead | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Director, Cell Therapy Translational Medicine & Bioanalysis | AstraZeneca | Shanghai, China | 2026-06-25 |
| Group Medical Manager (GU&GYN&GI Cancers) | AstraZeneca | Istanbul, Turkey | 2026-06-25 |
| Medical Science Liaison Manager (m/w/d) im Bereich Hypertension & Hyperkalemia - Nord-Ost (Berlin - Rostock - Magdeburg - Halle) | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Science Liaison Manager (m/w/d) im Bereich Hypertension & Hyperkalemia Region Mitte (Kassel - Marburg - Erfurt - Gรถttingen) | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Representative - Oncology (Davao) | AstraZeneca | Manila, Philippines | 2026-06-25 |
| Head of Medical Science Liaison Manager (m/w/d) Respiratory COPD | AstraZeneca | United Kingdom | 2026-06-25 |
| (Senior) Director, Clinical Pharmacology | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Affairs Manager Oncology (Lung Cancer) (m/w/d) | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Medical Science Liaison-Gyn-Chengdu | AstraZeneca | China | 2026-06-25 |
| Senior/Principal Physician (Cell Therapy) | AstraZeneca | United Kingdom | 2026-06-25 |
| Senior Medical Science Liaison (Neurology / Meta+) | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Medical Science Liaison (Neurology / Meta+) | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| VP, Clinical Development, Amyloidosis and Rare Cardiology | AstraZeneca | Boston, United States | 2026-06-25 |
| Global Development Medical Director, Late Respiratory and Immunology Clinical Development | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Medical Representative_ONC_GI/Hema(C) | AstraZeneca | Taiwan | 2026-06-25 |
| Global Medical Performance & Field Medical (MSL) Excellence Director, Respiratory & Immunology | AstraZeneca | Barcelona, Spain | 2026-06-25 |
| Global Medical Performance & Field Medical (MSL) Excellence Director, Cardiovascular, Renal & Metabolism (CVRM) | AstraZeneca | Barcelona, Spain | 2026-06-25 |
| Local Study Associate Director (LSAD) / Clinical Project Lead (m/w/d) | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Local Study Associate Director (LSAD) / Clinical Project Lead (m/w/d) | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Local Study Associate Director (LSAD) / Clinical Project Lead (m/w/d) | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Global Medical Affairs, Executive Director, Medical Capabilities, Training & MSL Excellence | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Field Clinical Advisor - Cell Therapy Clinical Operations | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Medical Science Liaison Manager im Bereich Immunology (m/w/d) Mitte (Frankfurt/Main, Mainz, Heidelberg, Saarbrรผcken) | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Science Liaison-HCC/BTC-Beijing | AstraZeneca | China | 2026-06-25 |
| Medical Science Liaison-LC-Guangzhou | AstraZeneca | China | 2026-06-25 |
| Medical Science Liaison Manager im Bereich Immunology/Pipeline (m/w/d) Region West (Mรผnster, Dรผsseldorf, Kรถln, Aachen) | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Science Liaison Manager im Bereich Immunology/Pipeline (m/w/d) Region Sรผd (Frankfurt/M, Heidelberg, Nรผrnberg, Mรผnchen) | AstraZeneca | United Kingdom | 2026-06-25 |
| Global Medical Head, Weight Management (Obesity & Cardiovascular-Kidney-Metabolic), Injectables Portfolio | AstraZeneca | Boston, United States | 2026-06-25 |
| Medical Science Liaison-HTN-Guangzhou | AstraZeneca | China | 2026-06-25 |
| Regional Medical Advisor - Oncology | AstraZeneca | India | 2026-06-25 |
| US Medical Director - COPD Biologics | AstraZeneca | United Kingdom | 2026-06-25 |
| Medical Representative - Oncology - Cebu | AstraZeneca | Manila, Philippines | 2026-06-25 |
| Senior Physician I/II (Early Oncology) | AstraZeneca | Shanghai, China | 2026-06-25 |
| Medical Advisor-Inhale | AstraZeneca | China | 2026-06-25 |
| Medical Science Liaison-LC-Beijing | AstraZeneca | China | 2026-06-25 |
| Medical Representative_ONC Breast Cancer (C) | AstraZeneca | Taiwan | 2026-06-25 |
| Clinical Operations Program Associate Manager | AstraZeneca | Shanghai, China | 2026-06-25 |
| Medical Advisor โ Oncology (Gynaecological Cancer) โ Czech Republic | AstraZeneca | Republic, United States | 2026-06-25 |
| US Medical Head, Early Assets | AstraZeneca | Wilmington, United States | 2026-06-25 |
| Medical Franchise Head, US Medical Affairs, Breast Cancer | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Medical Director, Respiratory, Early Clinical Development | AstraZeneca | Gaithersburg, United States | 2026-06-25 |